Recent Advancements in the Diversification and Applications of Boron-Containing Compounds in Medicinal Chemistry

Boron-containing compounds have made a significant impact on the field of medicinal chemistry since the discovery of Bortezomib (Velcade^®), a dipeptide boronic acid approved by the FDA in 2003 for the treatment of multiple myeloma. Since then, over the last two decades, four more boron-co...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Marielle B. Frooman, Moinak K. Deb, Jaxon Peters, Sasha Leggett, Nitesh Sanghai, Nafees Zahra Rizvi, Devi Atukorallaya, Geoffrey K. Tranmer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-11-01
Sarja:	Pharmaceuticals
Aiheet:	boron boron-containing compounds advanced drug delivery systems drug design biological molecules
Linkit:	https://www.mdpi.com/1424-8247/18/12/1798
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!